2024Äê5ÔÂ25ÈÕÊǵÚÎå¸öÊÓÉñ¾¼¹ËèÑׯ×ϵ¼²²¡£¨NMOSD£©»¼Õ߹ذ®ÈÕ¡£µÏÍþÖÆµÏÍþ¹ú¼ÊÁªºÏÈ«¹úÊýʮλר¼Ò¼°±±¾©²¡Í´ÌôÕ½¹«Òæ»ù½ð»áµÈ×éÖ¯£¬ÔÚÌì½ò¡¢ÖØÇì¡¢Ö£ÖÝ¡¢ÎÚ³ľÆë¡¢¹ãÖÝ¡¢Î人¡¢³¤´ºµÈ³ÇÊоٰì¶à³¡Ò½Ñ§ÂÛ̳ºÍר¼ÒÒåÕ½øÒ»²½ÆÕ¼°NMOSD·ÀÖÎ֪ʶ£¬ÌáÉýÈ«Éç»á¶ÔNMOSD»¼ÕߵĹØ×¢ÓëÖ§³Ö¡£

NMOSD»¼Õ߹ذ®ÈÕÖ÷Ìâ»î¶¯ÏÖ³¡
ÊÓÉñ¾¼¹ËèÑׯ×ϵ¼²²¡£¨NMOSD£©ÊÇÒ»ÖÖº±¼ûµÄ¡¢¸ß¸´·¢¡¢¸ßÖ²еÄÖÐÊàÉñ¾ÏµÍ³×ÔÉíÃâÒßÐÔ¼²²¡¡£¸Ã¼²²¡Ö÷ÒªËðº¦ÊÓÉñ¾ºÍ¼¹Ë裬»¼ÕßÒ׳öÏÖÊÓÎïÄ£ºý¡¢Ì±»¾¡¢ÌÛÍ´¡¢ÐÐ×ßÀ§ÄÑ¡¢Í·ÔΡ¢Å»ÍµÈÖ¢×´£¬ºÃ·¢ÓÚÇà׳Ä꣬ŮÐԾӶ࣬ÇÒ¼«Ò׸´·¢¡£2018Ä꣬NMOSD±»ÁÐÈë¡¶ÖйúµÚÒ»Åúº±¼û²¡Ä¿Â¼¡·¡£
ר¼ÒÌáÐÑ£¬NMOSDµÄÖ²ÐÂÊÓëÆä·¢×÷´ÎÊýÕýÏà¹Ø£¬·¢×÷´ÎÊýÔ½¶à£¬·¢ÉúʧÃ÷¡¢Ì±»¾µÈºóÒÅÖ¢µÄ·çÏÕ¾ÍÔ½¸ß¡£Òò´Ë£¬Ò»µ©³öÏÖ¶Ìʱ¼äÄÚÊÓÁ¦¼±¾çϽµ¡¢ÊÓҰȱËð¡¢¼¡Ìå·¦Á¦¡¢Ö«ÌåÓÐÕëÔú¸Ð»òÊø´ø¸ÐÒÔ¼°²»Ã÷ÔÒòðþÑ÷µÈÖ¢×´£¬Ð뾯ÌèÊÇ·ñî¾»¼NMOSD£¬Ó¦¾¡Ôçµ½Éñ¾ÄڿƾÍÕï¡£
2023Äê3ÔÂ1ÈÕ£¬µÏÍþÖÆµÏÍþ¹ú¼ÊµÄÒÁÄÎÀûÖéµ¥¿¹³ÉΪÖйúÊ׸öÄÉÈëÒ½±£µÄNMOSDÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê£¬À§ÈÅÎÒ¹úNMOSDÁìÓò¶àÄêµÄ¡°¾³ÄÚÎÞµÏÍþ¹ú¼Ê¡¢³¬ÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê¡¢µÏÍþ¹ú¼ÊÎïδÄÉÈëÒ½±£¡±µÈÕïÁÆÀ§¾³±»´òÆÆ£¬ÖйúNMOSDÉúÎïÖÆ¼ÁÖÎÁÆÐÂʱ´úÓÉ´Ë¿ªÆô¡£
²»½öÈç´Ë£¬³¤ÆÚÕÛÄ¥NMOSD»¼Õߵĸ´·¢ÎÊÌ⣬ÔÚµ¥¿¹ÀàÉúÎïÖÆ¼ÁµÄ°ïÖúÏÂÒ²µÃµ½Á˺ܺõĿØÖÆ¡£ÔÚµ¥¿¹ÀàÉúÎïÖÆ¼ÁÉÏÊÐǰ£¬ÎÒ¹úÖ÷Òª²ÉÓô«Í³ÃâÒßÒÖÖÆ¼Á½øÐÐNMOSD»º½âÆÚµÄÖÎÁÆ£¬ËäÈ»ÓÐÒ»¶¨ÁÆÐ§£¬µ«ÈÔÈ»ºÜÄÑ´ïµ½ÓÐЧ¿ØÖƸ´·¢µÄÖÎÁÆÄ¿±ê¡£¶øÒÁÄÎÀûÖéµ¥¿¹µÈÉúÎïÖÆ¼ÁµÄ³öÏÖÔòÈÃNMOSD»¼Õß¿´µ½ÁËÉÙ¸´·¢ÉõÖÁ²»¸´·¢µÄÏ£Íû¡£ºËÐÄÑо¿ÏÔʾ£¬ÒÁÄÎÀûÖéµ¥¿¹ÏÔÖø½µµÍAQP4-IgGÑôÐÔ»¼Õß·¢×÷·çÏÕ77%£»½ÓÊÜÒÁÄÎÀûÖéµ¥¿¹ÖÎÁÆÒ»Äêºó£¬92%»¼Õß¿ÉÔÚºóÐøÊ±¼ä³ÖÐøÎÞ·¢×÷[1]¡£

»ùÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê¶àÄêÀ´ÎªÌáÉýNMOSD»¼ÕßµÏÍþ¹ú¼ÊÎï¿É¼°ÐԵijÖÐøÍ¶ÈëºÍŬÁ¦£¬ÔÚµÚÎå¸öNMOSD»¼Õ߹ذ®ÈÕµ±Ì죬±±¾©²¡Í´ÌôÕ½¹«Òæ»ù½ð»áºÍÍÑËèÇʲ¡ÓѼÒÔ°ÏòµÏÍþÖÆµÏÍþ¹ú¼ÊÁªºÏ°ä·¢ÁË¡¶ÖÂл֤Êé¡·£¬²¢ÆÚ´ýÔÚδÀ´Ð¯ÊÖÊØ»¤¸ü¶àÉúÃüµÄÏ£Íû¡£
²Î¿¼ÎÄÏ×£º
[1]Bruce A C Cree, et al. Lancet. 2019 Oct 12;394(10206):1352-1363.
µÏÍþÖÆµÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖÆµÏÍþ¹ú¼ÊÆóÒµ£¬ÏÂÊôºÀɵÏÍþ¹ú¼ÊÒµ¡¢³£Öݺã°îµÏÍþ¹ú¼ÊÒµ¡¢µÏÍþÉúÎïÒ½µÏÍþ¹ú¼ÊµÈ×Ó¹«Ë¾£¬ÖØµã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò£¬ÖÂÁ¦ÓÚͨ¹ý³ÖÐø´´ÐÂÌá¸ßÈËÀàÉúÃüÖÊÁ¿¡£½ØÖÁĿǰ£¬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬´´ÐµÏÍþ¹ú¼ÊÓªÊÕÕ¼±ÈÒÑÍ»ÆÆÖÁ67.9%¡£¹«Ë¾Á¬Ðø¶àÄêλ¾ÓÈ«ÇòÖÆµÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖØµã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£¹«Ë¾ÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£
±¾ÎÄÖ¼ÔÚÌṩÓйء°µÏÍþÖÆµÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¡±»òÆä×Ó¹«Ë¾µÈ¹ØÁª·½£¨Í³³Æ¡°¹«Ë¾¡±£©µÄÏà¹ØÐÅÏ¢£¬²»¹¹³É¹«Ë¾ÐÅÏ¢Åû¶»òͶ×ÊÍÆ¼ö¡£
±¾ÎÄËù·¢²¼µÄÐÅÏ¢ÖпÉÄÜ»á°üº¬Ä³Ð©Ç°Õ°ÐÔ±íÊö£¬ÀýÈçÉæ¼°ÒµÎñºÍ²úƷǰ¾°£¬»ò¹«Ë¾¼Æ»®¡¢ÈÏÖª¡¢Ô¤ÆÚ¼°²ßÂÔ¡£ÕâЩ±íÊöÊǽ¨Á¢ÔÚÍÆ²âÐÔ¼ÙÉèµÄÊý¾Ý»ù´¡ÉϵÄÔ¤²â£¬²¢·ÇÊǶÔδÀ´·¢Õ¹µÄ±£Ö¤£¬ÒòÆäÐÔÖÊʹȻ¾ùÊÜÏà¹Ø·çÏպͲ»È·¶¨ÒòËØÓ°Ï죬ÆäÖв¿·Ö»¹²»Êܹ«Ë¾¿ØÖÆÇÒÄÑÒÔÔ¤ÁÏ£¬Í¶×ÊÕß½øÐÐͶ×ʾö²ßʱӦ½÷É÷ʹÓá£ÔÚʹÓá°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°ÆÚÍû¡±¼°ÆäËûÀàËÆ´ÊÓï½øÐбíÊöʱ£¬·²Ó빫˾ÓйصÄÐÅÏ¢±íÊö£¬¾ùÊôÓÚǰհÐÔ±íÊö¡£¹«Ë¾²¢ÎÞÒåÎñ¸üлòÐÞ¸ÄÕâЩǰհÐÔ±íÊö£¬¹«Ë¾¡¢¹«Ë¾¶Ê¡¢¹ÍÔ±¡¢´úÀí¸Å²»³Ðµ£ÒòÈκÎǰհÐÔ±íÊö²»ÄÜʵÏÖ»ò±ä³É²»ÕýÈ·¶øÒýÖµÄÈκÎÔðÈΡ£
±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢½ö¼°ÓÚÐÂΟ巢²¼Ö®ÈÕ£¬ÎÞÂÛÊÇ·ñ³öÏÖÐÂ×ÊÁÏ¡¢Î´À´Ê¼þ»òÆäËûÇé¿ö£¬³ý·Ç·¨ÂÉÒªÇ󣬹«Ë¾²¢ÎÞÔðÈλòÒåÎñ¸üлòÐ޸ĸõÈÐÅÏ¢¡£Í¶×ÊÕßÒ˲ÎÕÕµÏÍþÖÆµÏÍþ¹ú¼Ê£¨03692.HK£©¹«¸æ¼°²Æ±¨£¬ÒÔ»ñÈ¡½öÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢¡£